Atos Medical

Atos Medical

Malmö, Sweden· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Atos Medical is a long-established, commercial-stage medical device company focused exclusively on the niche but critical area of neck stoma care following laryngectomy or tracheostomy. Acquired by Coloplast in 2022, it operates as a distinct brand within the larger group, offering a comprehensive portfolio of products including voice prostheses, heat and moisture exchangers (HMEs), adhesives, tubes, and the TheraBite Jaw Motion Rehabilitation System. The company combines innovative product development with strong patient support services through its Atos Care program, positioning it as a holistic solution provider in a specialized therapeutic area with high customer loyalty.

Head and Neck Cancer RehabilitationRespiratory Care

Technology Platform

Mechanical and material science platform for neck stoma care, including Heat and Moisture Exchangers (HMEs), voice prostheses, adhesive systems, and the TheraBite jaw motion rehabilitation device.

Opportunities

Leveraging Coloplast's global distribution network to expand market reach, particularly in the US and Asia.
Growing the addressable market by addressing adjacent complications like trismus with the TheraBite system, thereby increasing revenue per patient within the core head and neck cancer population.

Risk Factors

Operating in a niche, size-limited market dependent on cancer incidence rates.
Integration risks following the Coloplast acquisition, including potential brand dilution or operational disruption.
Ongoing pricing and reimbursement pressures in global healthcare systems.

Competitive Landscape

Atos Medical is a recognized leader in the specialized niche of laryngectomy care, particularly for voice prostheses and HME systems. It faces competition from other specialized players like InHealth Technologies and broader medical device companies (e.g., Smiths Medical, Medtronic) in the tracheostomy tube segment. Its acquisition by Coloplast strengthens its competitive position through scale, resources, and a complementary ostomy care channel.